The Ethics of Conducting Clinical Trials With Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure Is Placebo Assignment Justified in Patients With Comorbid Diabetes Mellitus and Heart Failure?
[摘要]
[发布日期] [发布机构]
[效力级别] [学科分类]
[关键词] CARDIOVASCULAR OUTCOMES;EMPAGLIFLOZIN;RISK [时效性]
